文献速递神经肿瘤功能神经外科

拉曼光谱鉴别胶质瘤与正常脑组织:与5-ALA荧光引导手术的比较

Raman spectroscopy to differentiate between fresh tissue samples of glioma and normal brain: a comparison with 5-ALA-induced fluorescence-guided surgery.
PubMed 文献 · J Neurosurg · 2020-10-02

本研究用62例胶质瘤患者新鲜组织样本和11例无胶质瘤脑样本建立PCA-LDA机器学习预测模型,并用于8例超全切除后切除腔活检分类。拉曼光谱鉴别肿瘤与正常脑的敏感性0.96、特异性0.99、准确率0.99;在胶质母细胞瘤中显著优于5-ALA荧光(敏感性0.07、特异性1.00、准确率0.24,p=0.0009)。

要点

  • 拉曼光谱可准确鉴别新鲜胶质瘤与正常脑组织。
  • 在胶质母细胞瘤中拉曼光谱预测肿瘤优于5-ALA荧光。
  • 拉曼光谱有望与5-ALA荧光联用指导切除范围。

核心结论

  • 拉曼光谱能准确将新鲜组织样本分类为肿瘤与正常脑,且优于5-ALA诱导荧光。
  • 拉曼光谱可能成为与5-ALA荧光联用指导胶质瘤手术切除范围的重要术中工具。

研究设计与样本

  • 用62例胶质瘤患者新鲜组织样本和11例因癫痫行颞叶切除术的无胶质瘤脑样本的离体拉曼光谱,建立PCA-LDA机器学习预测模型。
  • 将该模型用于功能引导超全胶质瘤切除后切除腔新鲜活检的拉曼光谱分类。
  • 在胶质母细胞瘤病例中,记录切除腔活检部位的5-ALA诱导荧光,并与拉曼光谱模型预测肿瘤存在与否进行比较。

主要发现

  • PCA-LDA预测模型鉴别肿瘤与正常脑的敏感性0.96、特异性0.99、准确率0.99。
  • 在胶质母细胞瘤病例中,5-ALA诱导荧光的敏感性0.07、特异性1.00、准确率0.24,拉曼光谱性能显著更优(p=0.0009)。

临床怎么用

  • 术中可利用拉曼光谱对新鲜活检组织快速分类肿瘤与正常脑。
  • 在胶质母细胞瘤中,拉曼光谱可弥补5-ALA荧光敏感性不足。
  • 拉曼光谱可与5-ALA荧光联用以辅助判断切除范围。

局限性

  • 切除腔活检样本量较小,仅来自8例患者。
  • 研究为离体光谱分析,需进一步术中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Raman spectroscopy is a biophotonic tool that can be used to differentiate between different tissue types. It is nondestructive and no sample preparation is required. The aim of this study was to evaluate the ability of Raman spectroscopy to differentiate between glioma and normal brain when using fresh biopsy samples and, in the case of glioblastomas, to compare the performance of Raman spectroscopy to predict the presence or absence of tumor with that of 5-aminolevulinic acid (5-ALA)-induced fluorescence. METHODS: A principal component analysis (PCA)-fed linear discriminant analysis (LDA) machine learning predictive model was built using Raman spectra, acquired ex vivo, from fresh tissue samples of 62 patients with glioma and 11 glioma-free brain samples from individuals undergoing temporal lobectomy for epilepsy. This model was then used to classify Raman spectra from fresh biopsies from resection cavities after functional guided, supramaximal glioma resection. In cases of glioblastoma, 5-ALA-induced fluorescence at the resection cavity biopsy site was recorded, and this was compared with the Raman spectral model prediction for the presence of tumor. RESULTS: The PCA-LDA predictive model demonstrated 0.96 sensitivity, 0.99 specificity, and 0.99 accuracy for differentiating tumor from normal brain. Twenty-three resection cavity biopsies were taken from 8 patients after supramaximal resection (6 glioblastomas, 2 oligodendrogliomas). Raman spectroscopy showed 1.00 sensitivity, 1.00 specificity, and 1.00 accuracy for predicting tumor versus normal brain in these samples. In the glioblastoma cases, where 5-ALA-induced fluorescence was used, the performance of Raman spectroscopy was significantly better than the predictive value of 5-ALA-induced fluorescence, which showed 0.07 sensitivity, 1.00 specificity, and 0.24 accuracy (p = 0.0009). CONCLUSIONS: Raman spectroscopy can accurately classify fresh tissue samples into tumor versus normal brain and is superior to 5-ALA-induced fluorescence. Raman spectroscopy could become an important intraoperative tool used in conjunction with 5-ALA-induced fluorescence to guide extent of resection in glioma surgery.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Livermore LJ, Isabelle M, Bell IM, et al. Raman spectroscopy to differentiate between fresh tissue samples of glioma and normal brain: a comparison with 5-ALA-induced fluorescence-guided surgery. J Neurosurg. 2020. PMID: 33007757. doi:10.3171/2020.5.JNS20376

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。